Ergoteles’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-57,279
| Closed | -$85.9K | – | 1707 |
|
|
2023
Q1 | $85.9K | Buy |
57,279
+12,129
| +27% | +$18.2K | ﹤0.01% | 1112 |
|
|
2022
Q4 | $45.1K | Sell |
45,150
-65,519
| -59% | -$65.4K | ﹤0.01% | 1305 |
|
|
2022
Q3 | $199K | Sell |
110,669
-36,731
| -25% | -$66K | 0.01% | 1186 |
|
|
2022
Q2 | $427K | Buy |
+147,400
| New | +$427K | 0.01% | 910 |
|
|
2021
Q4 | – | Sell |
-13,100
| Closed | -$111K | – | 1707 |
|
|
2021
Q3 | $111K | Buy |
+13,100
| New | +$111K | ﹤0.01% | 1085 |
|